Wildy logo
(020) 7242 5778
enquiries@wildy.com

Wildy’s Book News

Book News cover photo

Vol 21 No 11 Nov/Dec 2016

Book of the Month

Cover of Criminal Injuries Compensation Claims

Criminal Injuries Compensation Claims

Price: £99.95

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


This book is now Out of Print.
A new edition has been published, the details can be seen here:
Pharmaceuticals, Biotechnology and the Law 3rd ed isbn 9781405781664

Pharmaceuticals, Biotechnology and the Law 2nd ed


ISBN13: 9780406914415
New Edition ISBN: 9781405781664
Published: January 2009
Publisher: LexisNexis Butterworths
Country of Publication: UK
Format: Hardback
Price: Out of print



Wildy's Book of the Month - February 2009

Pharmaceuticals Biotechnology and the Law is the definitive guide to the law in Europe relating to pharmaceuticals, biotechnology and their related areas such as medical devices.

Written by one of the country's leading patent and regulatory lawyers, this is the only text which comprehensively covers the wide variety of legal and regulatory issues which surround these industry sectors.

The book examines the background to, and the impact of, the law affecting this area. The text is primarily written from the perspective of European Community law, although in those relatively few areas where this is not harmonised it is written from the perspective of English law.

Subjects:
Intellectual Property Law, Medical Law
Contents:
Introduction and Overview;
Drug discovery and industry overview;
Intellectual property overview;
Regulatory overview;
Competition law overview;
Early stage R&D;
Regulatory issues associated with early stage pharmaceuticals R&D, including ethical issues associated with stem cells, and animal experimentation;
Special regulatory issues associated with biotechnology, including contained use and deliberate release;
Patents issues associated with early stage pharmaceuticals R&D;
Patents issues associated with biotechnology;
Agreements in early stage R&D;
Late stage R&D;
Regulatory issues associated with pharmaceuticals, including clinical trials;
Regulatory issues associated with late stage R&D in other applications of biotechnology than pharmaceuticals;
Regulatory issues associated with late stage R&D in other life sciences sectors;
Patents issues associated with late stage pharmaceuticals R&D
Agreements in late stage R&D;
Trade mark issues associated with pharmaceuticals;
Post Authorisation;
Agreements for exploiting proven products, including co-marketing and co-promotion;
Regulatory issues post authorisation for pharmaceuticals, including pricing;
Regulatory issues post associated in other applications of biotechnology than pharmaceuticals;
Product liability;
Parallel Imports and Generic Competition;
Parallel imports;
Patents and generic competition;
Regulatory data protection and generic competition;